• Nem Talált Eredményt

Expression change of the transient receptor potential ankyrin 1 (TRPA1) receptor in inflammatory bowel disease (IBD) and dextran sulfate-induced colitis in mice

N/A
N/A
Protected

Academic year: 2022

Ossza meg "Expression change of the transient receptor potential ankyrin 1 (TRPA1) receptor in inflammatory bowel disease (IBD) and dextran sulfate-induced colitis in mice"

Copied!
1
0
0

Teljes szövegt

(1)

EXPRESSION CHANGE OF THE TRANSIENT RECEPTOR POTENTIAL ANKYRIN 1 (TRPA1) RECEPTOR IN

INFLAMMATORY BOWEL DISEASE (IBD) AND DEXTRAN SULFATE-INDUCED COLITIS IN MICE

Kun J.

1,3

, Helyes Zs.

1,3

, Perkecz A.

1

, Gódi Sz.

2

, Szabó I.

2

, Pinter E.

1

Departments of

1

Pharmacology ,

2

1st Department of Internal Medicine, Faculty of Medicine;

3

Szentagothai Science Center, University of Pecs, 12 Szigeti Street, H-7624 Pecs, Hungary

BACKGROUND

The transient receptor potential ankyrin 1 (TRPA1) receptor has been implicated in thermo and pain sensation, hyperalgesia and neurogenic

inflammation. It is a receptor-ion channel complex functioning as a sensor of noxious stimulus, chemical irritants and cold. Besides sensory nerves it is also localized on non-neural structures such as dermal, epithelial, mucosal cells.

TRPA1 occurs in the GI tract and its activation on visceral sensory neurons leads to inflammation. Neural TRPA1 has been shown to induce and maintain colitis. However, the funcion of non-neural TRPA1 in this process has not been elucidated, yet. The aim of the present study was to detect the existence and expression change of non-neural TRPA1 receptors at the protein and mRNA level in human IBD and mouse colitis model.

METHODS

Patients: Human colon biopsies were derived from three groups of patients: 1.

patients with non-inflammatory conditions (n=5); 2. patients with colon tumors (n=8); 3. patients with ulcerative colitis or Crohn’s disease (n=12).

Colitis model: In female mice (C57BL/6 strain, weight: 20-25 g, age: 6-8 weeks), DSS colitis was induced by adding 2% DSS to the drinking water of six animals. Another six mice received only water as a control. Distal third of the colon was taken for further examination.

Quantitative real-time PCR: To measure non-neural, i.e. locally synthetized TRPA1 mRNA expression, qRT-PCR was performed on a Roche Light Cycler sequence detection system by TaqMan primers and probes following TaqMan universal PCR master mix protocol, quantitative real-time PCR was carried out with TaqMan primers and probes on a Roche LightCycler detection system.

Transcripts of beta-glucuronidase (GUSB) were determined as internal control.

RESULTS

According to our immunohistochemical evidence, in murine samples, Schwann cells and axons show TRPA1 immunopositivity in control and DSS-treated

samples , and also on macrophages in DSS-treated inflammed samples. A 3.3 fold increase of the TRPA1 mRNA was found in patients with IBD compared to the negative control group and a 2.6 fold increase compared to the tumor

patients (one-way ANOVA p=0.0028). In DSS-treated murine samples non-

neural TRPA1 receptor gene expression also inreased 8.1 fold (unpaired t-test p=0.0022) compared to the water-treated control group.

CONCLUSIONS

The elevation of non-neural TRPA1 receptor mRNA in both human IBD

samples and mouse colitis model may suggest a role for the extraneurally

localized receptor. Thus the modulatory role of non-neural TRPA1 receptors in the pathomechanism of IBD needs to be further investigated.

ACKNOWLEDGEMENTS

SROP-4.2.1.B-10/2/KONV-2010-0002, SROP-4.2.2.B-10/1/2010-0029, Hungarian Grant OTKA K81984

Immunohistochemistry: Immunohistochemistry was performed with polyclonal rabbit anti-TRPA1 primary and HRP-conjugated anti-rabbit secondary antibody on paraffin-embedded sections followed by diamino-benzidine (DAB)

development. For the detection of macrophages, monoclonal anti-CD68 (KP1) primary antibody was used. Hematoxylin-eosin nucluar staining was applied.

Figure 1. Relative expression of human TRPA1 receptor mRNA in non-inflamed control, tumorous and IBD samples is shown. Means ± SEM. One-way ANOVA: p=0.0028.

Figure 2. Relative expression of murine TRPA1 receptor mRNA normalized to the reference gene GUSB in water-treated control and DSS- treated colitis samples is shown. Means ± SEM.Unpaired t-test: p=0.0022.

Figure 3. Relative expression of murine TRPA1 receptor mRNA normalized to the reference gene GUSB in water-treated control and DSS- treated colitis samples is shown. Means ± SEM.Unpaired t-test: p=0.0051.

Figure 4. 100x. Photomicrograph of representative areas of

TRPA1 immunohistochemically labeled colon samples of control water-treated animals. TRPA1 immunopositivity is present on Schwann cells and axons (upper arrow) in the muscle layer and around blood vessels (lower arrow).

Insert: 600x. Schwann cells and axons are specifically stained by TRPA1 antibody.

Figure 5. 100x. Photomicrograph of representative areas of TRPA1 immunohistochemically labeled colon samples of DSS-treated

animals. TRPA1 immunopositivity is present on macrophages, Schwann cells and axons.

Insert: 200x. Macrophages with specific anti-CD68 (KP1) antibody staining.

Figure 6. 600x. Photomicrograph of representative area of TRPA1

immunohistochemically labeled colon sample of water-treated control animals. Schwann cells in the muscle layer are specifically marked (arrow).

Figure 7. 600x. Photomicrograph of representative area of TRPA1

immunohistochemically labeled colon

sample of DSS-treated animals. Schwann cells n the muscle layer are specifically marked (arrow).

Hivatkozások

KAPCSOLÓDÓ DOKUMENTUMOK

TIP39 expression is confined to PVG, PIL, and MPL while considerable PTH2 receptor expression is present in the infralimbic cortex, the innermost layer of other

Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in

SET protein expression was smaller in all 9-cis retinoic acid treated groups relative to control, but only reached the level of significance in the combined treated

Frolova L, Drastich P, Rossmann P et al (2008) Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases:

Background: Capsaicin-sensitive sensory neurons express several ion channels of the TRP family, such as transient receptor potential ankyrin 1 (TRPA1) and vanilloid

Comparing the relative gene expression for Kir and 2-pore ion channels in ventricles, we observed decreased gene expression for Kir2.2, Kir6.1, and SUR2 but, interestingly, the

EXPRESSION TYPES WIDE DISTRIBUTION IN THE BRAIN, PRE- AND POSTYNAPTIC RECEPTOR LOCATIONS, LIGAND BINDING THE EXTRACELLULAR N TERMINUS PART OF THE RECEPTOR.

Expression of calcitonin gene-related peptide1 receptor mRNA in human trigeminal ganglia and cerebral arteries.. Nerve fibers containing neuropeptide Y in the